Literature DB >> 2810339

Duchenne muscular dystrophy in Wales: a 15 year study, 1971 to 1986.

A M Norman1, C Rogers, J R Sibert, P S Harper.   

Abstract

A register of families with Duchenne muscular dystrophy (DMD) in Wales was set up in 1973 and has been regularly maintained ever since. All women at significant risk in these families were offered estimation of their carrier status by creatine kinase and pedigree analysis. A total of 225 of the 512 women tested was assigned a risk of carrying the DMD gene of less than 5%. One hundred and twenty live births from this group were notified to the register and only one was an affected male. This was the expected number and shows that the risks given were largely accurate. Women given a risk of 5% or greater were offered fetal sexing with termination of any male. Amniocentesis was of limited value and chorionic villus sampling, introduced in 1984, was acceptable to more women at risk. The incidence of DMD in Wales dropped from one in 3435 at the beginning of the study to one in 4046 by 1982, and the proportion of recurrent cases from 40% to 22%. Common reasons for recurrence were birth of a second affected boy before diagnosis of the first, and failure of families with affected dead members in previous generations to be notified to the register. Maintaining an accurate register of DMD families is an essential tool in their management.

Entities:  

Mesh:

Year:  1989        PMID: 2810339      PMCID: PMC1015694          DOI: 10.1136/jmg.26.9.560

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  4 in total

1.  Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening.

Authors:  A M Norman; M Upadhyaya; N S Thomas; K Roberts; P S Harper
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

2.  PEDIG--a computer program for calculation of genotype probabilities using phenotype information.

Authors:  I Heuch; F H Li
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

3.  Implications of diagnostic delay in Duchenne muscular dystrophy.

Authors:  T O'Brien; J R Sibert; P S Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.

Authors:  J R Sibert; P S Harper; R J Thompson; R G Newcombe
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

  4 in total
  6 in total

1.  Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening.

Authors:  A M Norman; M Upadhyaya; N S Thomas; K Roberts; P S Harper
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

2.  Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy.

Authors:  R A Smith; D K Williams; J R Sibert; P S Harper
Journal:  BMJ       Date:  1990-04-28

3.  The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

Authors:  A Clarke
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

4.  Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).

Authors:  Stuart J Moat; Donald M Bradley; Rachel Salmon; Angus Clarke; Louise Hartley
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

5.  Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands.

Authors:  A J van Essen; H F Busch; G J te Meerman; L P ten Kate
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

Review 6.  Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.

Authors:  Salvatore Crisafulli; Janet Sultana; Andrea Fontana; Francesco Salvo; Sonia Messina; Gianluca Trifirò
Journal:  Orphanet J Rare Dis       Date:  2020-06-05       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.